Literature DB >> 23931821

Peripheral nerve involvement in hereditary cerebellar and multisystem degenerative disorders.

José Berciano1, Antonio García, Jon Infante.   

Abstract

Hereditary ataxias (HA) encompass an increasing number of degenerative disorders characterized by progressive cerebellar ataxia usually accompanied by extracerebellar semeiology including peripheral nerve involvement. Classically, HA were classified according to their pathological hallmark comprising three main forms: (1) spinal form predominantly with degeneration of spinocerebellar tracts, posterior columns, and pyramidal tracts (Friedreich's ataxia, FA); (2) olivopontocerebellar atrophy (OPCA); and (3) cortical cerebellar atrophy (CCA). In the 1980s Harding proposed a clinico-genetic classification based upon age of onset, modality of transmission, and clinical semeiology. The main categories in this classification were as follows: (1) early onset cerebellar ataxia (EOCA) with age of onset below 25 years and usually with autosomal recessive (AR) transmission (this group encompasses FA and syndromes different from FA); (2) autosomal dominant cerebellar ataxia (ADCA) with adult onset and with either cerebellar-plus syndrome or pure cerebellar semeiology; and (3) idiopathic late onset onset cerebellar ataxia (ILOCA). With the advent of molecular genetics, the nosology of HA has been in a state of constant flux. At present EOCA comprises at least 17 genotypes (designated with the acronym of ARCA derived from AR cerebellar ataxia), whereas under the umbrella of ADCA 30 genotypes have been reported. In this chapter we will review peripheral nerve involvement in classical pathological entities (OPCA and CCA), ARCA, ADCA, and ILOCA paying special attention to the most prevalent syndromes in each category. As a general rule, nerve involvement is relatively common in any form of ataxia except ILOCA, the most common pattern being either sensory or sensorimotor neuronopathy with a dying-back process. An exception to this rule is AR spastic ataxia of Charlevoix-Saguenay where nerve conduction studies show the characteristic pattern of intermediate neuropathy implying that sacsin mutation causes both axonal and Schwann cell dysfunction.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Friedreich’s ataxia; SCA; autosomal dominant cerebellar ataxia; autosomal recessive cerebellar ataxia; axonal degeneration; demyelination; hereditary ataxia; nerve conduction studies; peripheral neuropathy; spinocerebellar degeneration; sporadic ataxia

Mesh:

Year:  2013        PMID: 23931821     DOI: 10.1016/B978-0-444-52902-2.00051-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  5 in total

1.  New findings in the ataxia of Charlevoix-Saguenay.

Authors:  José Gazulla; Isabel Benavente; Ana Carmen Vela; Miguel Angel Marín; Luis Emilio Pablo; Alessandra Tessa; María Rosario Barrena; Filippo Maria Santorelli; Claudia Nesti; Pedro Modrego; María Tintoré; José Berciano
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

Review 2.  History of Ataxias and Paraplegias with an Annotation on the First Description of Striatonigral Degeneration.

Authors:  José Berciano; José Gazulla; Jon Infante
Journal:  Cerebellum       Date:  2021-11-03       Impact factor: 3.648

3.  Transynaptic changes evident in peripheral axonal function after acute cerebellar infarct.

Authors:  William Huynh; Cindy S-Y Lin; Arun V Krishnan; Steve Vucic; Matthew C Kiernan
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

4.  NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.

Authors:  José Berciano; Kristien Peeters; Antonio García; Tomás López-Alburquerque; Elena Gallardo; Arantxa Hernández-Fabián; Ana L Pelayo-Negro; Els De Vriendt; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

5.  Clinical and neuroradiological features of spinocerebellar ataxia 38 (SCA38).

Authors:  Barbara Borroni; Eleonora Di Gregorio; Laura Orsi; Giovanna Vaula; Chiara Costanzi; Filippo Tempia; Nico Mitro; Donatella Caruso; Marta Manes; Lorenzo Pinessi; Alessandro Padovani; Alfredo Brusco; Loredana Boccone
Journal:  Parkinsonism Relat Disord       Date:  2016-04-27       Impact factor: 4.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.